In 2023, the mortality rate for trachea, bronchus, or lung malignant neoplasms in Germany stood at a certain rate, paving the way for a forecasted decline over the subsequent years. From 2024 to 2028, the standardized rate per hundred thousand men is anticipated to decrease steadily year-on-year. The rate is expected to fall from 51.3 in 2024 to 46.4 by 2028, illustrating a consistent downward trajectory, likely driven by improved healthcare interventions, preventive measures, and smoking cessation programs.

Future trends to watch for include:

Advancements in treatment options and early detection technologies.
Potential shifts in smoking prevalence due to regulatory changes or public health campaigns.
Impact of environmental factors and pollution control measures.